Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1657 of 5804
-
Immune cells armed with antibody take on pancreatic cancer
Disease control CompletedThis protocol will confirm toxicities and estimate the clinical efficacy of combining anti-CD3 x anti-EGFR bispecific antibody (EGFRBi) armed activated T cells (EGFR BATs) given to patients with locally advanced or metastatic pancreatic cancer who have received at least one dose …
Phase: PHASE1, PHASE2 • Sponsor: University of Virginia • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Shorter radiation after prostate surgery may be just as good
Disease control CompletedThis randomized phase III trial studies how well hypofractionated radiation therapy works compared to conventional radiation therapy after surgery in treating patients with prostate cancer. Hypofractionated radiation therapy delivers higher doses of radiation therapy over a short…
Phase: PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Engineered immune cells target tough leukemia in early trial
Disease control CompletedPatients with relapsed or refractory leukemia often develop resistance to chemotherapy and some patients who relapse following CD19 directed therapy relapse with CD19 negative leukemia. For this reason, the investigators are attempting to use T-cells obtained directly from the pa…
Phase: PHASE1 • Sponsor: Seattle Children's Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Can a simple MRI spot early success in brain cancer treatment?
Knowledge-focused OngoingThis phase II trial studies how well dynamic susceptibility contrast-enhanced magnetic resonance imaging (DSC-MRI) works in measuring relative cerebral blood volume (rCBV) for early response to bevacizumab in patients with glioblastoma that has come back. DSC-MRI may help evaluat…
Phase: NA • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Knowledge-focused
Last updated Jul 19, 2026 00:00 UTC
-
New drug combo targets tough breast cancer
Disease control CompletedA Phase I of Olaparib with Radiation Therapy in Patients With Inflammatory, Loco-regionally Advanced or Metastatic TNBC (triple negative breast cancer) or Patient With Operated TNBC with Residual Disease.
Phase: PHASE1 • Sponsor: Institut Curie • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Can a pill save hearing during CF lung treatment?
Disease control CompletedThe primary objective of this study is to determine the safety and efficacy of SPI-1005 treatment in CF patients with active pulmonary exacerbation that are receiving an IV course of tobramycin, determined by comparing hearing assessments, spirometry, Pharmacokinetic (PK), Physic…
Phase: PHASE2 • Sponsor: Sound Pharmaceuticals, Incorporated • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Your eyes could reveal Alzheimer's: new study uses retinal imaging to spot brain disease
Knowledge-focused Recruiting nowThis study aims to develop and evaluate biomarkers using non-invasive optical coherence tomography (OCT) and OCT angiography (OCTA) as well as ultra-widefield (UWF) fundus photography to assess the structure and function of the retinal and choroidal microvasculature and structure…
Sponsor: Duke University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:01 UTC
-
New radiation approach may reduce side effects in breast cancer treatment
Disease control CompletedThis study is to compare radiation toxicity of accelerated partial breast irradiation (ABPI) with whole breast irradiation (WBI) in low-risk breast cancer.
Phase: NA • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 08:14 UTC
-
Heart hole device shows promise for lung pressure relief
Disease control CompletedThis study aims to investigate safety and efficacy of Occlutech® AFR device in patients with severe pulmonary hypertension (PH).
Phase: NA • Sponsor: Occlutech International AB • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Your voice could reveal hidden cancer: AI listens for signs
Diagnosis CompletedParticipants diagnosed with oral cancer, oropharyngeal cancer, or oral potentially malignant lesions, as well as healthy controls, had their speech audio recordings collected for the development and validation of AI-driven models for diagnosis and prognosis prediction of oral can…
Sponsor: Yudong Xiao • Aim: Diagnosis
Last updated Jun 27, 2026 08:11 UTC
-
New combo therapy targets advanced lung cancer after relapse
Disease control CompletedThis is an open label, multi-institutional, single arm study with a dose escalation phase Ib cohort, followed by a phase II cohort of pembrolizumab and Imprime PGG. No randomization or blinding is involved.
Phase: PHASE1, PHASE2 • Sponsor: Lawrence Feldman, MD • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Could a common painkiller replace ibuprofen for preemie heart treatment?
Disease control CompletedMulticentric, double-blind clinical trial, which will evaluate the efficacy of iv paracetamol versus standard treatment with ibuprofen in the closure of patent ductus arteriosus in the preterm newborn. Secondarily, we intend to compare the safety of both treatments, increase our …
Phase: PHASE3 • Sponsor: Máximo Vento Torres • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Tailoring chemo by genetics and health may boost survival in older AML patients
Disease control CompletedAcute myeloid leukemia (AML) is among the most common hematologic malignancies in adults and accounts for approximately 10,000 deaths in the United States every year. AML is commonly diagnosed in sixth or seventh decades of life. The management of AML is complex in older patients…
Phase: PHASE2 • Sponsor: University of Nebraska • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Ear acupuncture tested as pain relief for breast cancer survivors
Symptom relief CompletedAuriculotherapy is a complementary medicine, with few side effects, without contraindication, inexpensive and not very restrictive.Its efficacy has been found in several tests especially for the treatment of intraoperative pain. It remains more controversial in other indications.…
Phase: NA • Sponsor: Centre Francois Baclesse • Aim: Symptom relief
Last updated Jun 26, 2026 15:33 UTC
-
Can alcohol and cannabis together worsen driving skills more than either alone?
Knowledge-focused CompletedAlcohol and cannabis are the two most widely used substances of abuse in the world and are the psychoactive substances most often found in seriously and fatally injured drivers. In a recent study, it was observed that individuals who reported both driving under the influence of a…
Phase: NA • Sponsor: Centre for Addiction and Mental Health • Aim: Knowledge-focused
Last updated Jul 26, 2026 00:00 UTC
-
Potassium pills may slow kidney decline in CKD patients
Disease control OngoingThe current high-sodium, low-potassium diet contributes to the high prevalence of high blood pressure (hypertension). Indeed, the anti-hypertensive effects of potassium supplementation are well-established. Hypertension is even more prevalent and resistant in patients with chroni…
Phase: NA • Sponsor: Erasmus Medical Center • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Can speech therapy slow language loss in progressive aphasia?
Symptom relief OngoingPrimary progressive aphasia (PPA) is a progressive neurological disorder that causes a gradual decline in communication ability as a result of selective neurodegeneration of speech and language networks in the brain. PPA is a devastating condition affecting adults as young as the…
Phase: NA • Sponsor: University of Texas at Austin • Aim: Symptom relief
Last updated Jun 27, 2026 07:57 UTC
-
Can radiation wake up the immune system against resistant head and neck cancer?
Disease control OngoingThis research study is studying immunotherapy in combination with radiation therapy as a possible treatment for head \& neck cancer that has worsened or spread to another organ or part of your body. The immunotherapy involved in this study is: MK-3475 (pembrolizumab or KEYTRUDA)…
Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New pill shows promise for Hard-to-Treat blood cancers in japanese patients
Disease control CompletedThis is a multicenter, open-label Phase 1 study of acalabrutinib, a selective and irreversible Bruton's tyrosine kinase inhibitor, in Japanese adult patients with advanced B-cell malignancies. This study is divided into 3 parts: Part 1 (dose-confirmation phase), Part 2 (dose-expa…
Phase: PHASE1 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Experimental combo targets tough blood cancers
Disease control Recruiting nowThis research study is studying a drug as a possible treatment for diagnosis of AML, BPDCN and high-risk MDS. The interventions involved in this study are: * SL-401 * Azacitidine * Venetoclax
Phase: PHASE1 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC